Estimation of Serum Interleukin-6 level as a Useful Marker for Clinical Severity of Sickle Cell Disease among Sudanese Patients

Authors

  • Alaaeddin M.Elzubeir Author

DOI:

https://doi.org/10.14741/ijmcr/v.5.3.20

Keywords:

Sickle Cell Disease, Severity, Serum IL-6, SCD Marker

Abstract

Background: Sickle cell disease (SCD) is an inherited disease characterized by a complex and varied physiopathology and exhibits wide clinical diversity. SCA’s variability and pose significant management challenges to all medical staff

Objectives: We aimed in this study to correlate between serum interleukin-6 level and the clinical severity events of SCD in Sudanese Patients

Method: Case control study conducted on 133 patients with Sickle cell disease were collected and level of serum Il-6 were determined by ELISA and compared to 93appearantly healthy individuals as Control group.
Result: There was significant association between elevation in serum IL-6 and development of complications in SCD, Chi squared (χ²) = 0.000 (P < 0.05).

Conclusion: These findings indicated that serum level of IL-6 may contribute to susceptibility to many crisis and may use as useful marker for early broadcasting tool for SCD crisis.

Downloads

Download data is not yet available.

References

Downloads

Published

31-05-2017

Issue

Section

Articles

How to Cite

Estimation of Serum Interleukin-6 level as a Useful Marker for Clinical Severity of Sickle Cell Disease among Sudanese Patients. (2017). International Journal of Multidisciplinary and Current Research, 5(3), 642-644. https://doi.org/10.14741/ijmcr/v.5.3.20